Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Cisplatin/Gemcitabine Regimen

View Patient Information

A regimen consisting of cisplatin and gemcitabine that can be used in the treatment of biliary tract, bladder, cervical, kidney, occult primary, pancreatic, ovarian, fallopian tube, primary peritoneal, and vulvar cancers, peritoneal and pleural mesothelioma, non-small cell lung cancer (NSCLC), gestational trophoblastic neoplasia (GTN), cancer of the nasopharynx, and ampullary adenocarcinoma.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	cisplatin-gemcitabine cisplatin-gemcitabine regimen cisplatin/gemcitabine GC regimen GemCis gemcitabine-cisplatin gemcitabine-cisplatin regimen gemcitabine/cisplatin gemcitabine/cisplatin regimen

Cisplatin/Gemcitabine Regimen

Search NCI's Drug Dictionary